Even during spooky season, don’t let your innovations disappear into the shadows. VU & VUMC faculty with new ideas, technologies, or discoveries are encouraged to disclose them to CTTC through the Inventor Portal.

The Vanderbilt Venture Partners program is designed to provide greater and more meaningful interactions between faculty and staff entrepreneurs, their startup companies, and qualified seed and Series A investors looking for the latest tech-enabled market opportunities. Learn More

Congratulations to Alan Bentley, assistant vice chancellor of technology transfer and intellectual property development, the recipient of the 2025 Leadership Excellence Award! From his nomination: “Alan is a visionary who inspires others to think similarly and encourages the team to think boldly about the work that we do.’”

The award was presented by Chancellor Daniel Diermeier and Vice Chancellor of People, Culture and Belonging Sydney Savion at the Fall Staff Assembly. 

Virtuoso Surgical, Inc., a Vanderbilt-founded company developing new robotic tools for endoscopic surgery, has received FDA Breakthrough Device Designation for its Surgical Robotic System for bladder lesion removal. Learn more about Virtuoso's progress.

Thursday, November 20, 2025 • 12:00 PM • Alumni Hall Memorial Room 

Register Here

Whether you're looking to co-develop new solutions, expand your research horizons, or drive industry advancements, these opportunities provide unique ways to engage with top-tier organizations and make a lasting impact. Opportunities include Pfizer Independent Medical Education Grant, Amazon Science, GenScript, Johnson & Johnson, Emily's Entourage, Bio-Rad Laboratories, Genentech, Haleon, and more. 

Paul Harris is a Professor of Biomedical Informatics & Biomedical Engineering, and the VP of Research Informatics at VUMC. Paul's journey at REDCap exemplifies how academic innovation, designed for accessibility and supported by strategic partnerships, can transform research processes and human lives worldwide.

The inaugural event, hosted by CTTC and Vanderbilt Health Brock Family Center for Applied Innovation, convened faculty entrepreneurs and other individuals who have launched startups to commercialize Vanderbilt technologies for an opportunity to share with their fellow founders their insights, stories, strategies, and challenges. View Event Recap

This month, the licensing team had an intense five-day run in which they completed TEN licenses, including four royalty-bearing exclusive licenses and two new startups launched.

* includes end-user software and materials licenses along with conventional technology licenses 

Stephen leads our New Ventures team in their efforts to advance entrepreneurship and new venture creation and support programs across the Vanderbilt campus, in the greater Nashville area, and throughout Tennessee. 

View his leadership profile

CTTC welcomes Virinchi Juttukonda as a Senior Licensing Officer. He will focus on licensing software and AI-related technologies, an increased emphasis for the office. Learn more about Virinchi's story & CTTC's internship program

Congratulations to Daniel Fabbri and the Brim Analytics team for securing funding extension from ARPA-H. Fabbri's project - Democratized, AI-Guided Chart Abstraction Platform (DAGCAP) has previously received Innovation Catalyst Funding and Brim's reach now extends well beyond Vanderbilt. Read More

Vanderbilt faculty joined United for Medical Research’s MyWHY campaign by answering a simple but powerful question: Why is medical research important to you?

Their stories revealed the people, experiences and motivations behind their work. Read their stories

12,440,147 – “Systems and Methods for Evaluating and Mitigating Problem Behavior by Detecting Precursors” (Nilanjan Sarkar, Zhaobo Zheng, Amy Weitlauf, John Staubitz, Zachary Warren, James Dieffenderfer)

12,448,380 – “Positive Modulators of the Muscarinic Acetylcholine Receptor M4” (Craig Lindsley, Darren Engers, Kayla Temple, Alison Gregro, Alexa Richardson, Madeline Long)

12,448,632 – “Guanidine Degradation Enzyme and Methods of Use” (Jianping Yu, Bo Wang)